Intracellular trafficking of TREM2 is regulated by presenilin 1

Yingjun Zhao, Xiaoguang Li, Timothy Huang, Lu Lin Jiang, Zhenqiu Tan, Muxian Zhang, Irene Han Juo Cheng, Xin Wang, Guojun D Bu, Yun Wu Zhang, Qi Wang, Huaxi Xu

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Genetic mutations in triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to a variety of neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Parkinson's disease. In the brain, TREM2 is highly expressed on the cell surface of microglia, where it can transduce signals to regulate microglial functions such as phagocytosis. To date, mechanisms underlying intracellular trafficking of TREM2 remain elusive. Mutations in the presenilin 1 (PS1) catalytic subunit of the γ-secretase complex have been associated with increased generation of the amyloidogenic Aβ (amyloid-β) 42 peptide through cleavage of the Aβ precursor amyloid precursor protein. Here we found that TREM2 interacts with PS1 in a manner independent of γ-secretase activity. Mutations in TREM2 alter its subcellular localization and affects its interaction with PS1. Upregulation of PS1 reduces, whereas downregulation of PS1 increases, steady-state levels of cell surface TREM2. Furthermore, PS1 overexpression results in attenuated phagocytic uptake of Aβ by microglia, which is reversed by TREM2 overexpression. Our data indicate a novel role for PS1 in regulating TREM2 intracellular trafficking and pathophysiological function.

Original languageEnglish (US)
Article numbere405
JournalExperimental and Molecular Medicine
Volume49
Issue number12
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Presenilin-1
Myeloid Cells
Amyloid Precursor Protein Secretases
Microglia
Mutation
Neurodegenerative diseases
Amyloid beta-Protein Precursor
Amyloid
Cell Surface Receptors
Phagocytosis
Brain
Neurodegenerative Diseases
Parkinson Disease
Catalytic Domain
Alzheimer Disease
Up-Regulation
Down-Regulation
Peptides

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Zhao, Y., Li, X., Huang, T., Jiang, L. L., Tan, Z., Zhang, M., ... Xu, H. (2017). Intracellular trafficking of TREM2 is regulated by presenilin 1. Experimental and Molecular Medicine, 49(12), [e405]. https://doi.org/10.1038/emm.2017.200

Intracellular trafficking of TREM2 is regulated by presenilin 1. / Zhao, Yingjun; Li, Xiaoguang; Huang, Timothy; Jiang, Lu Lin; Tan, Zhenqiu; Zhang, Muxian; Cheng, Irene Han Juo; Wang, Xin; Bu, Guojun D; Zhang, Yun Wu; Wang, Qi; Xu, Huaxi.

In: Experimental and Molecular Medicine, Vol. 49, No. 12, e405, 01.01.2017.

Research output: Contribution to journalArticle

Zhao, Y, Li, X, Huang, T, Jiang, LL, Tan, Z, Zhang, M, Cheng, IHJ, Wang, X, Bu, GD, Zhang, YW, Wang, Q & Xu, H 2017, 'Intracellular trafficking of TREM2 is regulated by presenilin 1', Experimental and Molecular Medicine, vol. 49, no. 12, e405. https://doi.org/10.1038/emm.2017.200
Zhao, Yingjun ; Li, Xiaoguang ; Huang, Timothy ; Jiang, Lu Lin ; Tan, Zhenqiu ; Zhang, Muxian ; Cheng, Irene Han Juo ; Wang, Xin ; Bu, Guojun D ; Zhang, Yun Wu ; Wang, Qi ; Xu, Huaxi. / Intracellular trafficking of TREM2 is regulated by presenilin 1. In: Experimental and Molecular Medicine. 2017 ; Vol. 49, No. 12.
@article{7318dd915f1e4dd6b7f1fd50803e6329,
title = "Intracellular trafficking of TREM2 is regulated by presenilin 1",
abstract = "Genetic mutations in triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to a variety of neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Parkinson's disease. In the brain, TREM2 is highly expressed on the cell surface of microglia, where it can transduce signals to regulate microglial functions such as phagocytosis. To date, mechanisms underlying intracellular trafficking of TREM2 remain elusive. Mutations in the presenilin 1 (PS1) catalytic subunit of the γ-secretase complex have been associated with increased generation of the amyloidogenic Aβ (amyloid-β) 42 peptide through cleavage of the Aβ precursor amyloid precursor protein. Here we found that TREM2 interacts with PS1 in a manner independent of γ-secretase activity. Mutations in TREM2 alter its subcellular localization and affects its interaction with PS1. Upregulation of PS1 reduces, whereas downregulation of PS1 increases, steady-state levels of cell surface TREM2. Furthermore, PS1 overexpression results in attenuated phagocytic uptake of Aβ by microglia, which is reversed by TREM2 overexpression. Our data indicate a novel role for PS1 in regulating TREM2 intracellular trafficking and pathophysiological function.",
author = "Yingjun Zhao and Xiaoguang Li and Timothy Huang and Jiang, {Lu Lin} and Zhenqiu Tan and Muxian Zhang and Cheng, {Irene Han Juo} and Xin Wang and Bu, {Guojun D} and Zhang, {Yun Wu} and Qi Wang and Huaxi Xu",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/emm.2017.200",
language = "English (US)",
volume = "49",
journal = "Experimental and Molecular Medicine",
issn = "1226-3613",
publisher = "Korean Society of Med. Biochemistry and Mol. Biology",
number = "12",

}

TY - JOUR

T1 - Intracellular trafficking of TREM2 is regulated by presenilin 1

AU - Zhao, Yingjun

AU - Li, Xiaoguang

AU - Huang, Timothy

AU - Jiang, Lu Lin

AU - Tan, Zhenqiu

AU - Zhang, Muxian

AU - Cheng, Irene Han Juo

AU - Wang, Xin

AU - Bu, Guojun D

AU - Zhang, Yun Wu

AU - Wang, Qi

AU - Xu, Huaxi

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Genetic mutations in triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to a variety of neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Parkinson's disease. In the brain, TREM2 is highly expressed on the cell surface of microglia, where it can transduce signals to regulate microglial functions such as phagocytosis. To date, mechanisms underlying intracellular trafficking of TREM2 remain elusive. Mutations in the presenilin 1 (PS1) catalytic subunit of the γ-secretase complex have been associated with increased generation of the amyloidogenic Aβ (amyloid-β) 42 peptide through cleavage of the Aβ precursor amyloid precursor protein. Here we found that TREM2 interacts with PS1 in a manner independent of γ-secretase activity. Mutations in TREM2 alter its subcellular localization and affects its interaction with PS1. Upregulation of PS1 reduces, whereas downregulation of PS1 increases, steady-state levels of cell surface TREM2. Furthermore, PS1 overexpression results in attenuated phagocytic uptake of Aβ by microglia, which is reversed by TREM2 overexpression. Our data indicate a novel role for PS1 in regulating TREM2 intracellular trafficking and pathophysiological function.

AB - Genetic mutations in triggering receptor expressed on myeloid cells 2 (TREM2) have been linked to a variety of neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia and Parkinson's disease. In the brain, TREM2 is highly expressed on the cell surface of microglia, where it can transduce signals to regulate microglial functions such as phagocytosis. To date, mechanisms underlying intracellular trafficking of TREM2 remain elusive. Mutations in the presenilin 1 (PS1) catalytic subunit of the γ-secretase complex have been associated with increased generation of the amyloidogenic Aβ (amyloid-β) 42 peptide through cleavage of the Aβ precursor amyloid precursor protein. Here we found that TREM2 interacts with PS1 in a manner independent of γ-secretase activity. Mutations in TREM2 alter its subcellular localization and affects its interaction with PS1. Upregulation of PS1 reduces, whereas downregulation of PS1 increases, steady-state levels of cell surface TREM2. Furthermore, PS1 overexpression results in attenuated phagocytic uptake of Aβ by microglia, which is reversed by TREM2 overexpression. Our data indicate a novel role for PS1 in regulating TREM2 intracellular trafficking and pathophysiological function.

UR - http://www.scopus.com/inward/record.url?scp=85045018490&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045018490&partnerID=8YFLogxK

U2 - 10.1038/emm.2017.200

DO - 10.1038/emm.2017.200

M3 - Article

C2 - 29611543

AN - SCOPUS:85045018490

VL - 49

JO - Experimental and Molecular Medicine

JF - Experimental and Molecular Medicine

SN - 1226-3613

IS - 12

M1 - e405

ER -